Cargando…
Repeat Dosing of AAV2.5T to Ferret Lungs Elicits an Antibody Response That Diminishes Transduction in an Age-Dependent Manner
Readministration of recombinant adeno-associated virus (rAAV) may be necessary to treat cystic fibrosis (CF) lung disease using gene therapy. However, little is known about rAAV-mediated immune responses in the lung. Here, we demonstrate the suitability of the ferret for testing AAV2.5T-mediated CFT...
Autores principales: | Tang, Yinghua, Yan, Ziying, Lin, Shen, Huntemann, Eric D., Feng, Zehua, Park, Soo-Yeun, Sun, Xingshen, Yuen, Eric, Engelhardt, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648090/ https://www.ncbi.nlm.nih.gov/pubmed/33209961 http://dx.doi.org/10.1016/j.omtm.2020.09.008 |
Ejemplares similares
-
Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungs
por: Tang, Yinghua, et al.
Publicado: (2023) -
Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium
por: Ning, Kang, et al.
Publicado: (2023) -
Highly Efficient Transgenesis in Ferrets Using CRISPR/Cas9-Mediated Homology-Independent Insertion at the ROSA26 Locus
por: Yu, Miao, et al.
Publicado: (2019) -
Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease
por: He, Nan, et al.
Publicado: (2022) -
The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models
por: Uc, Aliye, et al.
Publicado: (2022)